SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I

Stopped Shortages of the active comparator drug (BCG) on the market worldwide and a growing uncertainty as to its future supply.

Conditions

• Urinary Bladder Neoplasms
• Urologic Neoplasms
• Urogenital Neoplasms
• Neoplasms
• Neoplasms by Site
• Urinary Bladder Diseases
• Urologic Diseases

Interventions

• DEVICE: Synergo + MMC
• DRUG: Bacillus Calmette-Guérin

Sponsor

Medical Enterprises Europe B.V.